000 01393 a2200409 4500
005 20250512083359.0
264 0 _c19850814
008 198508s 0 0 eng d
022 _a0014-2999
024 7 _a10.1016/0014-2999(85)90556-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHarron, D W
245 0 0 _aAntifibrillatory properties of alinidine after coronary artery occlusion in rats.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cApr 1985
300 _a301-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAnti-Arrhythmia Agents
650 0 4 _aArrhythmias, Cardiac
_xetiology
650 0 4 _aCardiovascular Agents
_xpharmacology
650 0 4 _aClonidine
_xanalogs & derivatives
650 0 4 _aCoronary Disease
_xcomplications
650 0 4 _aElectrocardiography
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHemodynamics
_xdrug effects
650 0 4 _aMale
650 0 4 _aMexiletine
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aRisk
650 0 4 _aVentricular Fibrillation
_xdrug therapy
700 1 _aBrezina, M
700 1 _aLillie, C
700 1 _aKobinger, W
773 0 _tEuropean journal of pharmacology
_gvol. 110
_gno. 3
_gp. 301-8
856 4 0 _uhttps://doi.org/10.1016/0014-2999(85)90556-4
_zAvailable from publisher's website
999 _c4012737
_d4012737